Pharmacologic differentiation of inflammation and fibrosis in the rat bleomycin model
- PMID: 16415276
- DOI: 10.1164/rccm.200505-717OC
Pharmacologic differentiation of inflammation and fibrosis in the rat bleomycin model
Abstract
Rationale: The model most often used to study the pathogenesis of pulmonary fibroses is the bleomycin (BLM)-induced lung fibrosis model. Several treatments have been efficacious in this model, but not in the clinic.
Objectives: To describe the time course of inflammation and fibrosis in the BLM model and to study the effect of timing of antiinflammatory and antifibrotic treatments on efficacy.
Methods and measurements: Rats were given single intratracheal injections of BLM on Day 0. At specified time points, 10 rats were killed and their lungs studied for proinflammatory cytokines and for profibrotic growth factor mRNA. After a single intratracheal injection of BLM on Day 0, rats were treated from Day 1 or 10 daily with oral prednisolone (10 mg/kg) or oral imatinib mesylate (50 mg/kg) for 21 d.
Results: After BLM administration, the expression of inflammatory cytokines was elevated and returned to background levels at later time points. Profibrotic gene expression peaked between Days 9 and 14 and remained elevated till the end of the experiment, suggesting a "switch" between inflammation and fibrosis in this interval. Antiinflammatory treatment (oral prednisolone) was beneficial when commenced at Day 1, but had no effect if administered from Day 10 onward. However, imatinib mesylate was effective independently of the dosing regime.
Conclusions: The response of the BLM model to antifibrotic or antiinflammatory interventions is critically dependent on timing after the initial injury.
Similar articles
-
[Effects of andrographolide on the concentration of cytokines in BALF and the expressions of type I and III collagen mRNA in lung tissue in bleomycin-induced rat pulmonary fibrosis].Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2011 Jul;27(7):725-9. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2011. PMID: 21722520 Chinese.
-
STY39, a novel alpha-melanocyte-stimulating hormone analogue, attenuates bleomycin-induced pulmonary inflammation and fibrosis in mice.Shock. 2011 Mar;35(3):308-14. doi: 10.1097/SHK.0b013e3181f8f15e. Shock. 2011. PMID: 20926985
-
[The effect of erythromycin on NF-kappa B activation and cytokines mRNA expression in bleomycin-induced pulmonary fibrosis in rats].Zhonghua Jie He He Hu Xi Za Zhi. 1999 Dec;22(12):725-7. Zhonghua Jie He He Hu Xi Za Zhi. 1999. PMID: 11776779 Chinese.
-
The efficacy of plant extract and bioactive compounds approaches in the treatment of pulmonary fibrosis: A systematic review.Biomed Pharmacother. 2017 Sep;93:666-673. doi: 10.1016/j.biopha.2017.06.052. Epub 2017 Jul 5. Biomed Pharmacother. 2017. PMID: 28688290 Review.
-
Interferon gamma-1b therapy for cryptogenic fibrosing alveolitis.Thorax. 2000 Aug;55 Suppl 1(Suppl 1):S37-40. doi: 10.1136/thorax.55.suppl_1.s37. Thorax. 2000. PMID: 10943637 Free PMC article. Review. No abstract available.
Cited by
-
Prevention of bleomycin-induced lung fibrosis via inhibition of the MRTF/SRF transcription pathway.Pharmacol Res Perspect. 2022 Dec;10(6):e01028. doi: 10.1002/prp2.1028. Pharmacol Res Perspect. 2022. PMID: 36426895 Free PMC article.
-
Histological hallmarks and role of Slug/PIP axis in pulmonary hypertension secondary to pulmonary fibrosis.EMBO Mol Med. 2019 Sep;11(9):e10061. doi: 10.15252/emmm.201810061. Epub 2019 Aug 29. EMBO Mol Med. 2019. PMID: 31468711 Free PMC article.
-
Dose-response Effects of Bleomycin on Inflammation and Pulmonary Fibrosis in Mice.Toxicol Res. 2010 Sep;26(3):217-22. doi: 10.5487/TR.2010.26.3.217. Toxicol Res. 2010. PMID: 24278527 Free PMC article.
-
Nuclear respiratory factor-1 negatively regulates TGF-β1 and attenuates pulmonary fibrosis.iScience. 2021 Dec 1;25(1):103535. doi: 10.1016/j.isci.2021.103535. eCollection 2022 Jan 21. iScience. 2021. PMID: 34977500 Free PMC article.
-
RNAi screening identifies a mechanosensitive ROCK-JAK2-STAT3 network central to myofibroblast activation.J Cell Sci. 2018 May 15;131(10):jcs209932. doi: 10.1242/jcs.209932. J Cell Sci. 2018. PMID: 29678906 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical